|
 |
 |
 |
 |
 |
 |
- Home
- Join or Change Subscription
- GSI Community
- For New Patients
- About GIST
- Pediatric GIST & Carney Triad
- Treatments
- Ask the Professional
- Learning Center
- Voices of GIST
- Educational Materials
- GIST Support Wiki
- Donate
XL418
 | |
 | |
XL418
This drug targets both Akt and p70S6K. For information at the website of Exelixis, the manufacturer. click here.
XL418 is currently in a phase I trial for solid tumors. For trial information go to this link at clinicaltrials.gov As of August 2008 the trial had been suspended due to low levels of drug.
